Table 9.

Mean glucose concentration (mmol/L) over time

ROI and intervention/control group	Visit 1	Visit 2	Visit 3	Visit 4
rACC
Pregabalin	1.18 (± 0.62)	1.17 (± 0.58)	0.92 (± 0.54)	1.21 (± 0.77)
Placebo	1.66 (± 0.59)	1.28 (± 0.52)	1.46 (± 0.53)	1.29 (± 0.59)
DLPFC
Pregabalin	1.71 (± 0.49)	1.74 (± 0.97)	1.48 (± 0.79)	1.63 (± 0.92)
Placebo	1.39 (± 0.61)	1.36 (± 0.73)	1.32 (± 0.56)	1.32 (± 0.73)
Thalamus left
Pregabalin	1.66 (± 0.51)	2.05 (± 0.51)	1.58 (± 0.69)	1.64 (± 0.91)
Placebo	2.15 (± 0.92)	1.69 (± 0.65)	1.89 (± 1.10)	2.37 (± 0.91)
Right thalamus
Pregabalin	2.45 (± 0.66)	2.07 (± 0.70)	2.13 (± 0.57)	2.24 (± 0.98)
Placebo	2.18 (± 0.65)	2.24 (± 0.89)	2.03 (± 0.92)	2.46 (± 1.27)

Data are presented as the mean ± SD